Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Stomach Neoplasms 1Lymphatic Metastasis 1

Interventions

Indocyanine Green 7Surgical Procedures, Operative 5Lymph Node Excision 5Radiotherapy, Intensity-Modulated 4Radiotherapy 4Radiosurgery 4Cisplatin 4gadofosveset trisodium 2TP protocol 2Sentinel Lymph Node Biopsy 2Radiation Dose Hypofractionation 2Magnetic Resonance Spectroscopy 2Electroporation 2Conversion to Open Surgery 2Control Groups 2Chemotherapy, Adjuvant 2Chemoradiotherapy 2Artificial Intelligence 2tislelizumab 1sarcolipin 1lncRNA LNMAT1, human 1gewf solution 1fluoroazomycin arabinoside 1X-Rays 1Technetium-99 1Technetium 1Surgery, Computer-Assisted 1Spectrum Analysis 1Specimen Handling 1Robotic Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphatic Metastasis × DNA Mismatch Repair × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡